Besse Medical

What Besse Medical does

Besse Medical is a specialty pharmaceutical distributor serving community-based physician practices in the United States. Operating as a wholly-owned brand under Cencora, Inc. (formerly AmerisourceBergen, rebranded in 2023) and tracing its heritage to 1948, the company distributes thousands of pharmaceuticals including biosimilars, controlled substances, seasonal vaccines, and a growing portfolio of specialty therapeutics such as CIMERLI, EXDENSUR, ICOTYDE, and HYMOVIS ONE. The company leverages Cencora's broader distribution network, which claims relationships with over 1,500 manufacturing partners and distributes 10 million healthcare products daily, to provide fast, secure specialty pharma supply to community practices.

The technology stack centers on three proprietary capabilities: ABC Order, a self-service supply management platform providing 24/7 ordering, order tracking, reporting, and online payment management; InfoDive, a practice business analytics product that surfaces missed billing, reimbursement gaps, MIPS adjustments, and CPT-code impacts based on Medicare patient volume; and inventory management solutions tailored for specialty and community practices, complemented by MIPS consulting services. No public-facing API or SDK is documented; the platform is delivered as a closed, login-gated experience.

Besse Medical operates a multi-channel go-to-market combining dedicated field sales account managers, inside sales (800.543.2111), direct distribution, ABC Order self-service, and Group Purchasing Organization (GPO) partnerships. Revenue is generated primarily through transaction-based product distribution fees and managed GPO contracting services, with pricing determined per account via volume and contract terms rather than publicly disclosed rates. The primary customer segment is community physician practices in specialties including retina, urology, and oncology, with secondary focus on Medicare-dependent practices requiring MIPS reporting and reimbursement optimization support.

Name

Besse Medical

Legal name

Cencora, Inc.

Website

https://www.besse.com

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

51–100 employees

Short description

Besse Medical is a US specialty pharmaceutical distributor serving community physician practices in retina, urology, oncology, and other specialties, distributing thousands of products via Cencora's network and offering ABC Order, InfoDive analytics, MIPS consulting, and GPO contracting services.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceutical Distribution

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

akta.pro secondary industry

Vaccines & Cold-Chain Pharmaceutical Distributors (HLAIAJAG)

Keywords

• Specialty pharmaceutical distribution
• Physician practice solutions
• Healthcare supply chain
• Pharmacy inventory management
• Practice business analytics

Headquarters

HQ city

West Chester

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Distribution: Besse Medical distributes thousands of pharmaceutical products to community physician practices, serving as a specialty supplier in the healthcare supply chain. Revenue is generated through product sales and distribution fees.
2. Practice Solutions and Analytics: Provides value-added services including practice business analytics (InfoDive), MIPS consulting, and inventory management solutions that support practice operations.
3. GPO Solutions: As the leading pharmaceutical distributor partner of GPOs in the USA, helps ensure access to lowest cost options and provides contracting opportunities to medical practices.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Besse Medical is a specialty pharmaceutical distributor serving community physician practices in the United States as a brand under Cencora (formerly AmerisourceBergen). The company distributes thousands of pharmaceutical products including biosimilars, controlled substances, seasonal vaccines, and specialty drugs, complemented by technology solutions such as the ABC Order online ordering platform, InfoDive practice business analytics, inventory management tools, MIPS consulting, and GPO solutions.

Product overview

Besse Medical is a specialty pharmaceutical distributor serving community physician practices, operating as part of Cencora (formerly AmerisourceBergen). The company offers a portfolio of pharmaceutical products and technology solutions. Core offerings include distribution of specialty pharmaceuticals (biosimilars, controlled substances, seasonal vaccines, and specific branded drugs like CIMERLI®, EXDENSUR, ICOTYDE™, and HYMOVIS® ONE), complemented by technology solutions including ABC Order online supply management and inventory management tools. Analytics and consulting services include InfoDive® for practice business analytics, GPIN for market research, and MIPS consulting services. The company connects physician practices with over 1,500 manufacturing partners through its network.

Differentiator

Problem solved

Functional benefit

Brands

• ABC Order: Online supply management platform for ordering, tracking, and reporting
• InfoDive
• Community Counts
• GPIN (Global Provider Insights Network)

Products and services

• Pharmaceutical Distribution Services Distribution of specialty pharmaceuticals including biosimilars, controlled substances, seasonal vaccines, and drug shortage products to community physician practices, as part of the Cencora network.
• ABC Order Online Supply Management Online platform providing 24-hour access to order placement, order tracking, reporting, and online payment management in a streamlined user experience for physician practices.
• Inventory Management Solutions Inventory management solutions designed specifically for specialty and community practices to strengthen control of inventory and payment verification.
• Specialty Solutions Comprehensive specialty solutions including GPO (Group Purchasing Organization) solutions, inventory management, and other services tailored for specialty and community practices.
• InfoDive Practice business analytics tool that helps uncover hidden revenue by identifying missed billing, reimbursement gaps, and performance variation. Provides data-driven insights on Medicare Physician Fee Schedule impacts, MIPS adjustments, and reimbursement analysis.
• Global Provider Insights Network (GPIN) Honoraria-based market research network connecting over 1,500 healthcare professionals. Enables manufacturers to better meet the needs of healthcare providers and patients through clinical expertise and feedback.
• MIPS Consulting Medicare Merit-based Incentive Payment System (MIPS) consulting services for retina practices and other specialties, helping practices simplify reporting, navigate program changes, and achieve optimal MIPS scores.
• Clinical Trial Navigator Suite of solutions designed to help clinical trials recruit with the help of community-based specialty providers, pairing pharma firms with providers to boost patient connection.
• CIMERLI (ranibizumab-eqrn) Vascular endothelial growth factor (VEGF) inhibitor injection for intravitreal use, indicated for treatment of neovascular (Wet) AMD, macular edema following RVO, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.
• EXDENSUR (depemokimab-ulaa) Interleukin-5 (IL-5) antagonist monoclonal antibody (humanized IgG1 kappa) indicated for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in adults and pediatric patients 12 years and older.
• ICOTYDE (icotrokinra) Interleukin-23 (IL-23) receptor antagonist indicated for treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years and older weighing at least 40 kg who are candidates for systemic therapy or phototherapy.
• HYMOVIS ONE (viscoelastic hyaluronan) Viscoelastic hyaluronan indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen).
• Biosimilars Biosimilar pharmaceutical products for healthcare providers, with whitepaper resources on the landscape of available biosimilars and the challenges and opportunities they present.
• Controlled Substances Distribution Distribution services for controlled substance pharmaceuticals for specialty and community practices.
• Seasonal Vaccines Distribution Distribution of seasonal vaccines for community-based specialty practices.

Quantifiable outcome

• Uncover hidden revenue through practice business analytics
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Cencora (Parent Company)coreStrategic or Co-development PartnerBesse Medical is a subsidiary of Cencora (formerly AmerisourceBergen). Cencora brings AmerisourceBergen and all companies and services together under one unified brand, expanding the network of pharmacists, physicians, caregivers and healthcare continuum partners.
• 1,500+ Manufacturing PartnerscoreTechnology or IntegrationBesse Medical's network works with over 1,500 manufacturing partners, ensuring physician practices have access to thousands of products. The company connects creators to caregivers, helping partners focus on innovation.
• GPIN (Global Provider Insights Network)coreStrategic or Co-development PartnerA network of over 1,500 healthcare professionals participating in honoraria-based market research. Clinical experience helps guide manufacturers to better meet provider and patient needs.
• Community CountsminorGTM or Marketing PartnerAn advocacy initiative representing community-based specialty providers with CMS, payers, legislators and patients. Amplifies the voice of providers to ensure specialty care in the community remains strong.
• Cencora Foundation and Family ReachminorStrategic or Co-development PartnerPartnership providing free financial guidebook resources for practices and patients dealing with financial struggles following serious diagnosis or job loss, including COVID-19 guidance.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• McKesson Corporation: McKesson is one of the Big 3 U.S. pharmaceutical distributors with a substantial specialty physician distribution arm serving community practices. It directly competes with Besse Medical for manufacturer contracts and physician practice relationships, and offers analogous services such as practice analytics and GPO solutions.
• Cardinal Health: Cardinal Health is the third of the Big 3 U.S. pharmaceutical wholesalers and runs a large specialty distribution business serving physician offices. Its product portfolio (specialty drugs, biosimilars, oncology), GPO solutions, and analytics services closely mirror Besse Medical's positioning.
• Cardinal Health Specialty Solutions (GAIA platform): Cardinal Health Specialty Solutions offers manufacturer services, distribution, and provider analytics for specialty practices and is a direct competitive analogue to Besse Medical's full-stack offering: distribution + practice analytics + GPO/MIPS advisory.
• H.D. Smith Wholesale Drug Co. H.D. Smith is a large privately-held pharmaceutical wholesaler with deep specialty drug distribution into community pharmacies and physician practices. It is directly comparable in business model — physician-channel distribution, GPO partnerships, and specialty drug portfolio management — though it is now part of AmerisourceBergen/Cencora since 2022.
• Anda Inc (now part of Teva/Allergan/PharmaLex): Anda was one of the largest U.S. specialty pharmaceutical distributors focused on physician offices, retail pharmacies, and hospitals, and was historically a direct rival to Besse Medical in generics and specialty distribution. It represents a comparable specialty-distribution business model serving community practitioners.
• Smith Drug Company (now part of Quest Pharmaceuticals): Smith Drug Company is a long-standing regional pharmaceutical wholesaler focused on independent pharmacies and physician practices. It is directly comparable to Besse Medical in its focus on community-based customers, GPO access, and specialty product distribution.

Broad incumbents

• Cencora (formerly AmerisourceBergen): Cencora is Besse Medical's parent company and one of the world's largest pharmaceutical distributors. It is comparable because it operates in the same core business (specialty pharmaceutical distribution) at much larger scale, including physician-channel distribution arms and manufacturer-services offerings.
• Walgreens Specialty Pharmacy (Walgreens Boots Alliance): Walgreens operates a large specialty pharmacy network that competes for specialty patient fulfillment and increasingly for physician-office distribution partnerships. It is comparable as a major specialty drug channel player, though its primary model is retail/specialty pharmacy fulfillment rather than physician-practice wholesale.

Emerging players

• Avella Specialty Pharmacy: Avella is a specialty pharmacy and distribution company focused on complex therapeutics including oncology, fertility, and HIV. It is comparable to Besse Medical as a focused specialty drug distributor targeting clinical practices and complex patient populations.
• ICS (Innovative Cold Chain Solutions) / Specialty Pharmacy Distributors: Specialty distributors focused on cold-chain biologics and limited-distribution drugs serving specialty physician practices. They are comparable to Besse Medical in handling specialty/cold-chain drug logistics but with narrower product breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/bessemedical
• Facebookfacebook.com/bessemedical
• LinkedInlinkedin.com/company/bessemedical

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Besse Medical